title: Reduction of side effects of specific immunotherapy by premedication with antihistaminics and reduction of maximal dosage to 50.000 SQ-U/ml.
authors.forename: R
authors.initials: R
authors.lastname: Jarisch
authors.forename: M
authors.initials: M
authors.lastname: Götz
authors.forename: W
authors.initials: W
authors.lastname: Aberer
authors.forename: R
authors.initials: R
authors.lastname: Sidl
authors.forename: A
authors.initials: A
authors.lastname: Stabel
authors.forename: J
authors.initials: J
authors.lastname: Zajc
authors.forename: A
authors.initials: A
authors.lastname: Fördös
mesh_terms: D000485:Allergens / Q000008:administration & dosage*; D000818:Animals; D004306:Dose-Response Relationship, Immunologic; D006634:Histamine H1 Antagonists / Q000008:administration & dosage*; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D011292:Premedication
chemical_list: D000485:Allergens; D006634:Histamine H1 Antagonists